Neeta Medicose Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.57 M
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.70 M
- Revenue Growth 11.81%
- Profit Growth 27.87%
- Ebitda 62.98%
- Net Worth 15.12%
- Total Assets -0.98%
About Neeta Medicose
Neeta Medicose Pvt. Ltd. (NMPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 April 1991 and has a history of 33 years and ten months. Its registered office is in Indore, Madhya Pradesh, India.
The Corporate was formerly known as Neeta Medicos Pvt. Ltd. The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.57 M.
The company has closed loans amounting to ₹0.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Om Pasari, Govind Pasari, and Shrigopal Pasari serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85120MP1991PTC006339
-
Company No.
006339
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 1991
-
Date of AGM
16 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Neeta Medicose?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Om Pasari
|
Director | 04-Apr-1991 | Current |
|
Govind Pasari
|
Director | 04-Apr-1991 | Current |
|
Shrigopal Pasari
|
Director | 04-Apr-1991 | Current |
Financial Performance of Neeta Medicose.
Neeta Medicose Pvt. Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 11.81% increase. The company also saw a substantial improvement in profitability, with a 27.87% increase in profit. The company's net worth Soared by an impressive increase of 15.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neeta Medicose?
In 2021, Neeta Medicose had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹0.70 M
Charges Breakdown by Lending Institutions
- Uco Bank : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 1996 | Uco Bank | ₹0.70 M | Satisfied |
How Many Employees Work at Neeta Medicose?
Unlock and access historical data on people associated with Neeta Medicose, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neeta Medicose, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neeta Medicose's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.